Galena Biopharma, Inc. (NASDAQ:GALE) Trend Analysis released that data from the Company's Phase 1/2a trial of GALE-301, a Folate Binding Protein (FBP)-derived immunotherapy, will be presented at the upcoming Society for Immunotherapy of Cancer 29th Annual Meeting. Galena Biopharma, Inc. (NASDAQ:GALE) stock price closed at $1.95 with the total traded volume of 1.17 Million shares. Its price to sales ratio ended at 32.00. Its market capitalization is 232.1 Million. The stock owned by the Financial Institutions was 19.50% while by insiders was 0.50%.Computer Sciences Corporation (NYSE:CSC) Trend Analysis released that its net income for the Q2 of $151M or $1.04 a share, as compared to $232M or $1.54 a share for the year-ago quarter. EPS from continuing operations for the Q2 were $1.18, as compared to $1.01 in the previous year quarter. Computer Sciences Corporation (NYSE:CSC) begun last trade with a price of $56.78 and throughout the trading session climbed at a high of $60.34. The day-trade ended with -0.03% to $59.67. The stock is going forward to its 52 week low with 21.00% and lagging behind from its 52 week high price with -8.58%. CSC last month stock price volatility remained 1.86%.Newcastle Investment Corp. (NYSE:NCT) Trend Analysis released that the spin-off of New Senior Investment Group Inc. (SNR) was successfully finished on November 6, 2014. Starting on November 7, 2014, New Senior will begin trading on the New York Stock Exchange. Newcastle Investment Corp. (NYSE:NCT) has the market capitalization of 249.7 Million. Shares of firm moved down -81.90% to close at $4.26 with the total traded volume of 7.18 Million.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
